KRYS — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

11.4

Margin Of Safety %

-6

Put/Call OI Ratio

0.38

EPS Next Q Diff

0.05

EPS Last/This Y

0.65

EPS This/Next Y

2.85

Price

264.08

Target Price

324.78

Analyst Recom

1.17

Performance Q

7.88

Upside

-9.3%

Beta

0.55

Ticker: KRYS

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	KRYS	258.61	0.45	5.83	4684
2026-03-10	KRYS	260.79	0.45	0.07	4698
2026-03-11	KRYS	254.85	0.45	0.04	4716
2026-03-12	KRYS	251.34	0.45	0.12	4730
2026-03-13	KRYS	251.31	0.45	0.11	4730
2026-03-17	KRYS	256.01	0.34	0.35	5741
2026-03-18	KRYS	251.01	0.34	0.00	5752
2026-03-19	KRYS	258.05	0.34	0.96	5745
2026-03-20	KRYS	251.46	0.33	0.21	5753
2026-03-23	KRYS	249.7	0.54	0.01	3790
2026-03-24	KRYS	247.11	0.38	0.05	4818
2026-03-25	KRYS	254.45	0.38	0.03	4833
2026-03-26	KRYS	251.4	0.38	2.14	4825
2026-03-27	KRYS	245.69	0.38	0.08	4824
2026-03-30	KRYS	246.66	0.38	0.06	4841
2026-03-31	KRYS	258.44	0.38	0.53	4826
2026-04-01	KRYS	259.03	0.38	0.00	4819
2026-04-02	KRYS	260.83	0.38	1.71	4820
2026-04-06	KRYS	261.41	0.38	2.67	4818
2026-04-07	KRYS	263.81	0.38	0.00	4812
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	KRYS	258.49	15.9	57.9	7.83
2026-03-10	KRYS	260.70	15.9	55.2	7.83
2026-03-11	KRYS	254.91	15.9	47.7	7.83
2026-03-12	KRYS	251.16	15.9	49.6	7.83
2026-03-13	KRYS	247.37	15.9	49.4	7.83
2026-03-17	KRYS	256.17	15.9	59.0	7.83
2026-03-18	KRYS	251.07	15.9	48.3	7.83
2026-03-19	KRYS	258.04	15.9	60.1	7.83
2026-03-20	KRYS	251.68	15.9	47.3	7.83
2026-03-23	KRYS	249.52	15.9	51.4	7.83
2026-03-24	KRYS	246.99	15.9	50.8	7.83
2026-03-25	KRYS	254.80	15.9	61.1	7.83
2026-03-26	KRYS	251.57	15.9	50.0	7.83
2026-03-27	KRYS	245.71	15.9	47.7	7.83
2026-03-30	KRYS	246.76	21.4	54.5	7.71
2026-03-31	KRYS	258.09	22.7	64.3	7.73
2026-04-01	KRYS	258.91	22.7	53.5	7.73
2026-04-02	KRYS	260.63	22.7	54.9	7.73
2026-04-06	KRYS	261.73	22.7	54.1	7.73
2026-04-07	KRYS	264.08	22.7	55.5	7.73
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	KRYS	-6.12	-0.13	10.89
2026-03-10	KRYS	-6.12	-0.13	10.89
2026-03-11	KRYS	-6.12	-0.13	11.64
2026-03-12	KRYS	-6.12	-0.13	11.64
2026-03-13	KRYS	-6.12	-0.13	11.64
2026-03-17	KRYS	-6.12	-1.38	11.64
2026-03-18	KRYS	-6.12	-1.38	11.64
2026-03-19	KRYS	-6.12	-1.38	11.64
2026-03-20	KRYS	-6.12	-1.38	11.64
2026-03-23	KRYS	-6.12	-1.42	11.64
2026-03-24	KRYS	-6.12	-1.42	11.64
2026-03-25	KRYS	-6.12	-1.42	11.40
2026-03-26	KRYS	-6.12	-1.42	11.40
2026-03-27	KRYS	-6.12	-1.42	11.40
2026-03-30	KRYS	-6.12	-1.35	11.40
2026-03-31	KRYS	-6.12	-1.35	11.40
2026-04-01	KRYS	-6.12	-1.35	11.40
2026-04-02	KRYS	-6.12	-1.35	11.40
2026-04-06	KRYS	-6.12	-1.35	11.40
2026-04-07	KRYS	-6.12	-1.35	11.40
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.7

Avg. EPS Est. Current Quarter

1.47

Avg. EPS Est. Next Quarter

1.75

Insider Transactions

-6.12

Institutional Transactions

-1.35

Beta

0.55

Average Sales Estimate Current Quarter

112

Average Sales Estimate Next Quarter

127

Fair Value

247.78

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

11.5

Max Drawdown 5-Year %

-51.3

Target Price

324.78

P/E

38.57

Forward P/E

26.62

PEG

1.05

P/S

19.83

P/B

6.32

P/Free Cash Flow

40.85

EPS

6.84

Average EPS Est. Cur. Y

7.73

EPS Next Y. (Est.)

10.58

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

52.64

Relative Volume

0.81

Return on Equity vs Sector %

-10.7

Return on Equity vs Industry %

5.9

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.13

EBIT Estimation

55.5

◆ KRYS Healthcare

$263.99

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

10/25

Volume

7/15

Valuation

12/20

TP/AR

4/10

Options

6/10

RSI

55.4

Range 1M

83.8%

Sup Dist

1.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

19/30

Estimates

7/20

Inst/Vol

2/15

Options

7/10

EPS Yr

11.7%

EPS NY

29.8%

52W%

79.7%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟡 HOLD +22.9% upside

Quality

21/30

Valuation

9/30

Growth

16/25

Stability

7/10

LT Trend

3/5

Upside

+22.9%

Quality

MoS

-6%

Krystal Biotech, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 295

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

KRYS

Latest News

—

Caricamento notizie per KRYS…

stock quote shares KRYS – Krystal Biotech, Inc. Stock Price stock today

news today KRYS – Krystal Biotech, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch KRYS – Krystal Biotech, Inc. yahoo finance google finance

stock history KRYS – Krystal Biotech, Inc. invest stock market

stock prices KRYS premarket after hours

ticker KRYS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: KRYS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y